Funny thing, it is probably not going to work in many people with autism anyway. Or work in a way where the side effects are worse than the "mild autism". Henc

Funny thing, it is probably not going to work in many people with autism anyway. Or work in a way where the side effects are worse than the "mild autism". Hence, it needs to be actually phase 2 trialled properly for this indication. If the indication requires a genetic test beforehand, that's a minor ethical problem right there, in terms of privacy.